Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Patient page. Multiple sclerosis and vitamin D.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Generic Midamor
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Validity and reliability of VO2-max measurements in persons with multiple sclerosis.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.

Pages